Global Pruritus Therapeutic Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Pruritus Therapeutic Industry By The Forecast Year 2029?

The pruritus therapeutic market has demonstrated substantial growth in recent years. It is projected to expand from $14.29 billion in 2024 to $15.38 billion in 2025, recording a compound annual growth rate (CAGR) of 7.6%. This historical expansion can be ascribed to several factors, including the increasing prevalence of pruritus, advancements in research and development, a growing aging population, the expansion of healthcare infrastructure, heightened awareness among patients, and various collaborations and partnerships.

The pruritus therapeutic market is projected to experience substantial expansion over the next few years. It is anticipated to grow to “$21.88 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period can be attributed to continuous research and innovation, the expansion of emerging markets, increasing healthcare expenditure, the personalized medicine trend, and regulatory support for novel developments. Major trends expected in the forecast period include the integration of telemedicine and digital health, technological advancements, the adoption of telehealth and digital health solutions, the evolving global regulatory landscape, the development of biologics and immunomodulators, and patient-centric approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9925&type=smp

Which Drivers Are Shaping The Pruritus Therapeutic Industry’s Market Share?

The rising prevalence of skin conditions is a major factor driving the expansion of the pruritus therapeutic market. These skin conditions encompass various dermatological ailments like acne, eczema, skin cancer, psoriasis, and vitiligo, all of which impact the skin. Pruritus therapeutics are utilized in the treatment of numerous skin diseases because pruritus is a prevalent symptom in the majority of these disorders. For example, data from the American Academy of Dermatology Association, a US-based dermatology organization, indicated in April 2022 that melanoma was projected to cause 7,650 deaths in 2022, comprising 5,080 males and 2,570 women. Furthermore, the American Cancer Society, a US-based voluntary organization, reported in January 2023 that an estimated 97,610 new melanoma cases are anticipated to be diagnosed in the United States in 2023, with approximately 58,120 occurring in men and 39,490 in women. Consequently, the growing occurrence of skin disorders is expected to fuel the pruritus therapeutic market.

Which Key Segments Fueling The Pruritus Therapeutic Market?

The pruritus therapeuticmarket covered in this report is segmented –

1) By Type: Corticosteroids; Antihistamines; Local Anesthetics; Counterirritants; Immunosuppressant; Calcineurin Inhibitors; Others Types

2) By Disease Type: Atopic Dermatitis Or Eczema; Allergic Contact Dermatitis; Urticaria; Cutaneous T-Cell; Other Disease Types

3) By Application: External Use; Oral; Injection

4) By End Use: Hospitals; Clinics; Other Uses

Subsegments:

1) By Corticosteroids: Topical Corticosteroids; Systemic Corticosteroids

2) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines

3) By Local Anesthetics: Topical Local Anesthetics; Injectable Local Anesthetics

4) By Counterirritants: Menthol-Based Products; Camphor-Based Products

5) By Immunosuppressants: Systemic Immunosuppressants; Topical Immunosuppressants

6) By Calcineurin Inhibitors: Tacrolimus; Pimecrolimus

7) By Other Types: Antidepressants; Phototherapy Treatments; Herbal Remedies

What Key Innovation Trends Are Fueling Advancements In The Pruritus Therapeutic Market?

Product innovation stands out as a significant trend gaining traction in the pruritus therapeutic market. Key companies operating within the pruritus therapeutic market are concentrating on developing advanced medications and treatments for pruritus and related conditions. For example, in August 2022, Maruho Co., Ltd., a Japan-based pharmaceutical company, introduced the Mitchga Subcutaneous Injection 60 mg Syringes, which is an anti-IL-31 receptor humanized monoclonal antibody, designed for treating itching associated with atopic dermatitis. This marks the first antibody drug capable of inhibiting IL-31 signaling. IL-31 is recognized as a neuroimmune cytokine linked to pruritus and skin inflammation as atopic dermatitis progresses. The substance functions by preventing IL-31 from binding to its receptor, thereby suppressing both itch and skin inflammation connected with atopic dermatitis.

Which Major Firms Are Strengthening Their Position In The Pruritus Therapeutic Industry?

Major companies operating in the pruritus therapeutic market include Astellas Pharma Inc., Bristol-Myers Squibb Company, Cipla Inc., Eli Lilly and Company, Galderma Laboratories LP, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Abbott Laboratories, Almirall SA, Eisai Co. Ltd., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Lupin Chemicals Ltd., Cara Therapeutics Inc., EPI Health LLC, AbbVie Inc., Albireo Pharma Inc., Bayer AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Huapont Life Sciences Co. Ltd., LEO Pharma AS, MC2 Therapeutics Ltd., Novan Inc., Trevi Therapeutics Inc., UCB SA, Viatris Inc., Teva Pharmaceutical Industries Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

Which Region Is Projected To Lead The Pruritus Therapeutic Market During The Forecast Period?

North America was the largest region in the pruritus therapeutic market in 2024. The regions covered in the pruritus therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Pruritus Therapeutic Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9925&type=smp

Browse Through More Reports Similar to the Global Pruritus Therapeutic Market 2025, By The Business Research Company

Healthcare Nanotechnology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-nanotechnology-global-market-report

Healthcare Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-service-global-market-report

Home Healthcare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/home-healthcare-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795